Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...